
浏览全部资源
扫码关注微信
1.北京中医药大学 生命科学学院,北京 100029
2.北京中医药大学 东方医院,北京 100078
刘佳静,在读硕士,从事中医药免疫调节作用研究,E-mail:1109072713@qq.com
彭桂英,博士,副教授,从事中医药免疫调节作用研究,E-mail:penggy@bucm.edu.cn
收稿日期:2021-05-10,
网络出版日期:2021-07-07,
纸质出版日期:2021-09-05
移动端阅览
刘佳静,李秋逸,马沛广等.基于PKCθ/STAT3信号通路探讨虎杖苷抑制溃疡性结肠炎小鼠Th17细胞的效应[J].中国实验方剂学杂志,2021,27(17):40-45.
LIU Jia-jing,LI Qiu-yi,MA Pei-guang,et al.Polydatin Ameliorated Colonic Inflammation via Precluding Phosphorylation of PKCθ/STAT3 Pathway to Inhibit Th17 Cells in Mice with Ulcerative Colitis[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(17):40-45.
刘佳静,李秋逸,马沛广等.基于PKCθ/STAT3信号通路探讨虎杖苷抑制溃疡性结肠炎小鼠Th17细胞的效应[J].中国实验方剂学杂志,2021,27(17):40-45. DOI: 10.13422/j.cnki.syfjx.20211739.
LIU Jia-jing,LI Qiu-yi,MA Pei-guang,et al.Polydatin Ameliorated Colonic Inflammation via Precluding Phosphorylation of PKCθ/STAT3 Pathway to Inhibit Th17 Cells in Mice with Ulcerative Colitis[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(17):40-45. DOI: 10.13422/j.cnki.syfjx.20211739.
目的
2
探讨虎杖苷对小鼠溃疡性结肠炎(UC)的治疗作用,并通过其调控蛋白激酶C
θ
(PKC
θ
)/信号转导与转录激活因子3(STAT3)通路信号对辅助性T细胞17(Th17)细胞效应的抑制作用探讨其治疗UC的作用机制。
方法
2
32只雄性C57BL/6小鼠随机分为正常组、模型组、虎杖苷组(0.045 g·kg
-1
)及柳氮磺吡啶组(0.5 g·kg
-1
)。采用3%葡聚糖硫酸钠(DSS)溶液给与小鼠自由饮水构建UC模型,虎杖苷和柳氮磺吡啶组于造模前0.5 h灌胃给药,连续7 d,正常组及模型组给予等体积生理盐水灌胃。末次给药后取结肠组织,苏木素-伊红(HE)染色观察结肠组织病理变化,流式细胞术检测结肠黏膜固有层中Th17比例,酶联免疫吸附测定法(ELISA)检测血清中白细胞介素-17A(IL-17A)的表达。磁珠分选提取C57BL/6小鼠脾脏CD4
+
T细胞进行体外培养,加入细胞刺激合剂刺激并随机分为正常组、模型组、虎杖苷低、高剂量组。流式细胞术检测虎杖苷对Th17效应的影响及蛋白免疫印迹法(Western blot)检测磷酸化PKC
θ
和STAT3的蛋白表达。
结果
2
与正常组比较,模型组小鼠体质量明显下降、疾病活动指数(DAI)评分显著升高(
P
<
0.01),结肠黏膜上皮破损并可见黏膜及黏膜下层炎细胞浸润明显,结肠黏膜固有层中Th17的比例显著升高(
P
<
0.01),血清IL-17A的含量显著增加(
P
<
0.01);与模型组比较,虎杖苷和柳氮磺吡啶组体质量及DAI评分均有显著的改善(
P
<
0.01),结肠组织损伤程度明显改善,结肠黏膜固有层中Th17的比例显著下降(
P
<
0.01),血清中IL-17A的含量显著下降(
P
<
0.01)。体外实验显示,与正常组比较,模型组Th17细胞比例显著增加(
P
<
0.01),PKC
θ
和STAT3的磷酸化水平显著升高(
P
<
0.01);与模型组比较,虎杖苷组Th17细胞比例显著下降(
P
<
0.01),PKC
θ
和STAT3的磷酸化水平显著降低(
P
<
0.01)。
结论
2
虎杖苷能够抑制PKC
θ
以及STAT3的磷酸化表达,进而抑制Th17细胞分泌IL-17A,改善肠黏膜炎性病理,对UC起治疗作用。
Objective
2
To investigate the therapeutic effect of polydatin on ulcerative colitis (UC) in mice and its regulation of protein kinase C
θ
(PKC
θ
)/signal transducer and activator of transcription 3(STAT3) signaling on T helper cell 17(Th17) and its mechanism in the treatment of UC.
Method
2
The 32 male C57BL/6 mice were randomly divided into normal group, model group, polydatin group (0.045 g·kg
-1
) and sulfasalazine group (0.5 g·kg
-1
). The UC model was established by giving 3% dextran sodium sulfate (DSS) solution to free drinking water in mice. Polydatin and sulfasalazine groups were given by gavage 0.5 h before modeling for 7 days. The normal group and model group were given the same amount of normal saline. After the last administration, the colonic tissue was taken and hematoxylin-eosin (HE) was used to observe the pathological changes of colonic tissue. Flow cytometry was used to detect the proportion of Th17 in the lamina propria of colonic mucosa. The expression of interleukin-17A (IL-17A) in serum was detected by enzyme-linked immunosorbent assay (ELISA). Polydatin was added to CD4
+
T cells purified from spleen of C57BL/6 mice by magnetic-activated cell sorting (MACS) under the stimulation of cell stimulation cocktail
in vitro
in order to detect its impact on PKC
θ
and STAT3 phosphorylation.
Result
2
Compared with normal group, the body weight was significantly decreased, and disease activity index (DAI) scores of the model group was significantly increased (
P
<
0.01), the colonic mucosal epithelium was damaged and inflammatory cells infiltration in the mucosa and submucosa was obvious, the proportion of Th17 in the lamina propria of colonic mucosa was significantly increased (
P
<
0.01), and the content of serum IL-17A was significantly increased (
P
<
0.01). Compared with the model group, the weight and DAI score of polydatin and sulfasalazine groups were significantly improved (
P
<
0.01), the degree of colon tissue damage was significantly improved, the proportion of Th17 in colon mucosa lamina propria was significantly decreased (
P
<
0.01), and the content of IL-17A in serum was significantly decreased (
P
<
0.01).
In vitro
experiments showed that polydatin could significantly inhibit the phosphorylation of PKC
θ
and STAT3 in Th17 (
P
<
0.01) as well as IL-17A secretion.
Conclusion
2
Polydatin can improve the ulcerative colitis in mice via inhibiting the phosphorylation of PKC
θ
and STAT3 to preclude IL-17A secreting in Th17.
彭昊 , 董筠 . 中西医结合治疗溃疡性结肠炎研究进展 [J]. 河南中医 , 2021 , 41 ( 3 ): 448 - 453 .
方莹 , 孙丽娜 , 韩亚楠 , 等 . 炎症性肠病患儿血清Th17相关细胞因子表达及其意义 [J]. 中国实用儿科杂志 , 2020 , 35 ( 2 ): 137 - 141 .
张慧俭 , 周鹏飞 , 刘世举 , 等 . 消溃方灌肠治疗溃疡性结肠炎模型大鼠的作用机制研究 [J]. 北京中医药大学学报 , 2019 , 42 ( 7 ): 577 - 583 .
CHATILA T , SILVERMAN L , MILLER R , et al . Mechanisms of T cell activation by the calcium ionophore ionomycin [J]. J Immunol , 1989 , 143 ( 4 ): 1283 - 1289 .
ZHANG E Y , KONG K F , ALTMAN A . The yin and yang of protein kinase C-theta (PKC θ ):a novel drug target for selective immunosuppression [J]. Adv Pharmacol , 2013 , 66 : 267 - 312 .
LITHERLAND G J , ELIAS M S , HUI W , et al . Protein kinase C isoforms zeta and iota mediate collagenase expression and cartilage destruction via STAT3-and ERK-dependent c-fos induction [J]. J Biol Chem , 2010 , 285 ( 29 ): 22414 - 22425 .
林丽容 , 陈一斌 . 浅谈溃疡性结肠炎的中医治疗体会 [J]. 湖北中医杂志 , 2021 , 43 ( 3 ): 56 - 58 .
赵宝明 , 胡荫奇 , 李国栋 , 等 . 虎地肠溶胶囊治疗中医痢疾湿热蕴结证的随机对照临床试验 [J]. 临床医药文献电子杂志 , 2019 , 6 ( 33 ): 27 - 29,32 .
周怡 , 郭龙 , 贺静 , 等 . 虎地肠溶胶囊治疗轻中度溃疡性结肠炎的疗效分析 [J]. 临床医药文献电子杂志 , 2019 , 6 ( A2 ): 159 .
国家药典委员会 . 中华人民共和国药典:一部 [M]. 北京 : 中国医药科技出版社 , 2020 : 217 - 218 .
高守红 , 杨少麟 , 范国荣 . 虎杖苷的研究进展 [J]. 药学实践杂志 , 2005 ( 3 ): 145 - 147 .
吕婷婷 , 杨雷 , 沈磊 . 虎杖苷对葡聚糖硫酸钠诱导小鼠溃疡性结肠炎的作用及其对Hedgehog通路影响 [J]. 胃肠病学和肝病学杂志 , 2018 , 27 ( 11 ): 1228 - 1232 .
张莉 , 李园园 , 史梅 , 等 . 虎杖苷与白藜芦醇体外抗肠道病毒71型的初步研究 [J]. 临床检验杂志 , 2014 , 32 ( 10 ): 779 - 783 .
李亚兰 , 刘佳静 , 马沛广 , 等 . 葛根芩连汤调控MMP-9/p38 MARK途径修复溃疡性结肠炎小鼠肠黏膜上皮屏障功能 [J]. 中国实验方剂学杂志 , 2021 , 27 ( 4 ): 8 - 15 .
吴笑 , 夏俊东 , 方珂 , 等 . 溃疡性结肠炎中西医治疗临床研究进展 [J]. 中西医结合研究 , 2021 , 13 ( 2 ): 118 - 121 .
吴娜 , 杜鑫冲 , 于永强 , 等 . 重度溃疡性结肠炎患者糖皮质激素治疗反应的相关因素分析 [J]. 胃肠病学和肝病学杂志 , 2015 , 24 ( 7 ): 847 - 850 .
李玥 , 钱家鸣 . 免疫抑制剂在炎症性肠病治疗中的应用进展 [J]. 临床荟萃 , 2016 , 31 ( 8 ): 824 - 827 .
YAO J , WANG J Y , LIU L , et al . Polydatin ameliorates DSS-induced colitis in mice through inhibition of nuclear factor-kappaB activation [J]. Planta Med , 2011 , 77 ( 5 ): 421 - 427 .
PERITORE A F , D'AMICO R , CORDARO M , et al . PEA/polydatin:anti-inflammatory and antioxidant approach to counteract DNBS-induced colitis [J]. Antioxidants (Basel) , 2021 , 10 ( 3 ): 464 .
WAN Z , ZHOU Z , LIU Y , et al . Regulatory T cells and T helper 17 cells in viral infection [J]. Scand J Immunol , 2020 , 91 ( 5 ): e12873 .
KREBS C F , SCHMIDT T , RIEDEL J H , et al . T helper type 17 cells in immune-mediated glomerular disease [J]. Nat Rev Nephrol , 2017 , 13 ( 10 ): 647 - 659 .
UENO A , JEFFERY L , KOBAYASHI T , et al . Th17 plasticity and its relevance to inflammatory bowel disease [J]. J Autoimmun , 2018 , 87 : 38 - 49 .
曹铮 . G蛋白偶联受体介导的蛋白激酶C激活及其下游信号通路机制研究 [D]. 杭州 : 浙江大学 , 2020 .
HUANG K P . The mechanism of protein kinase C activation [J]. Trends Neurosci , 1989 , 12 ( 11 ): 425 - 432 .
MÉRIDA I , ARRANZ-NICOLÁS J , RODRÍGUEZ-RODRÍGUEZ C , et al . Diacylglycerol kinase control of protein kinase C [J]. Biochem J , 2019 , 476 ( 8 ): 1205 - 1219 .
杜丽蕊 . PKC θ 在T细胞活化和IL-2表达中的作用 [J]. 国外医学:免疫学分册 , 2004 ( 6 ): 346 - 350 .
ALTMAN A , KONG K F . Protein kinase C inhibitors for immune disorders [J]. Drug Discov Today , 2014 , 19 ( 8 ): 1217 - 1221 .
KWON M J , MA J , DING Y , et al . Protein kinase C θ promotes Th17 differentiation via upregulation of STAT3 [J]. J Immunol , 2012 , 188 ( 12 ): 5887 - 5897 .
0
浏览量
29
下载量
4
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621